REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Pharma Medica (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Pharma Medica Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Pharma Medica is an enterprise in Lithuania, with the main office in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on November 14, 2016. 3 (2025) employees currently work for UAB Pharma Medica. There was a net sales revenue drop of 40.64% reported in UAB Pharma Medica’s latest financial highlights for 2024. The net profit margin of UAB Pharma Medica decreased by 18.81% in 2024.

Headquarters
Kalvariju g. 151
Vilnius; Vilnius county; Postal Code: LT-08248

Contact Details: Purchase the UAB Pharma Medica report to view the information.

Basic Information
Total Employees:
Purchase the UAB Pharma Medica report to view the information.
Registered Capital:
Purchase the UAB Pharma Medica report to view the information.
Financial Auditors:
Purchase the UAB Pharma Medica report to view the information.
Incorporation Date:
November 14, 2016
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Pharma Medica report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-40.64%
Total operating revenue
-40.64%
Net Profit (Loss) for the Period
-88.89%
Total Equity
3.3%
Net Profit Margin
-18.81%
Return on Equity (ROE)
-26.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?